[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371999-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371999-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","3d-printed-biodegradable-and-biocompatible-intraperitoneal-implants-loaded-with-folic-acid-targetedph-sensitivedoxorubicinloaded-hydroxyapatite-nanoparticles-for-systemic-treatment-of-metastatic-breast-cancer","3D printed, biodegradable, and biocompatible intraperitoneal implants loaded with folic acid-targeted/pH-sensitive/doxorubicinloaded hydroxyapatite nanoparticles for systemic treatment of metastatic breast cancer","","Three-dimensional porous scaffolds designed for controlled drug release are increasingly used in chemotherapy to sustain drug delivery and lower systemic toxicity. This study integrates drug-loaded nanocarriers into 3D-printed scaffolds, enabling traceable constructs for medical imaging such as CT. Doxorubicin-loaded, folic acid-targeted, pH-sensitive nanohydroxyapatite (Dox@nHA-FA) is incorporated into Gel/PCL/HA scaffolds, followed by characterization of release, mechanics, microstructure, and degradation. In mice models, CT monitoring shows the optimized composition degrades with moderate disintegration by 14 days and demonstrates strong antitumor and antimetastatic efficacy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/3d-printed-biodegradable-and-biocompatible-intraperitoneal-implants-loaded-with-folic-acid-targetedph-sensitivedoxorubicinloaded-hydroxyapatite-nanoparticles-for-systemic-treatment-of-metastatic-breast-cancer/371999/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/3d-printed-biodegradable-and-biocompatible-intraperitoneal-implants-loaded-with-folic-acid-targetedph-sensitivedoxorubicinloaded-hydroxyapatite-nanoparticles-for-systemic-treatment-of-metastatic-breast-cancer/371999.png","ImageObject",300,407,{"name":42,"@type":43},"anakgang17","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What therapeutic goal do the 3D-printed intraperitoneal implants target?","Question",{"text":63,"@type":64},"They aim to provide controlled, sustained chemotherapy drug release while reducing systemic toxicity, specifically for systemic treatment of metastatic breast cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How are the drug-loaded constructs fabricated and enabled for imaging?",{"text":68,"@type":64},"Doxorubicin-loaded, folic acid-targeted, pH-sensitive nanohydroxyapatite nanocarriers are synthesized and incorporated into gelatin/polycaprolactone/hydroxyapatite (Gel/PCL/HA) scaffolds via 3D printing, with radio-opaque properties enabling CT monitoring of degradation.",{"name":70,"@type":61,"acceptedAnswer":71},"What efficacy and monitoring outcomes were reported in vivo?",{"text":72,"@type":64},"In tumor-bearing Balb/c mice, scaffold degradation is monitored by CT-scan, and the optimized Gel/PCL/HA(Dox@HA-FA) composition shows substantial reductions in tumor volume and metastatic liver colonies, along with histopathology and blood biochemistry confirming biocompatibility.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371999,1790240290,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},962090883568,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Kefayat etal. Journal of Nanobiotechnology (2026) 24:39  \n[https://doi.org/10.1186/s12951-025-03854-5](https://doi.org/10.1186/s12951-025-03854-5)  \nJournal of Nanobiotechnology  \nRESEARCH Open Access  \n3D printed, biodegradable, and biocompatible intraperitoneal implants loaded with folic acid-targeted/pH-sensitive/doxorubicinloaded hydroxyapatite nanoparticles for systemic treatment of metastatic breast cancer  \nAmirhosein Kefayat 1,2,3, Fatemeh Molaabasi3*, Mahshid Bahrami4, Mojtaba Karami5, Motahareh Mirzadeh8, Esfandyar Askari6, Amin Hajian3, Fatemeh Gharemani7, Zahra Mirzavandi8, Mohammad Rafienia8,9 and Seyed Ali Poursamar8*  \nAbstract  \nThree-dimensional porous scaffolds with the capability of controlled drug release have gained increasing interest in chemotherapy due to their sustained release of drugs and ability to reduce systemic toxicity. In  \nthis study, we advanced this concept by incorporating drug-loaded nanocarriers into 3D-printed scaffolds, creating trackable constructs for medical imaging such as CT-scan. Doxorubicin-loaded/folic acid-targeted pHsensitive nanohydroxyapatite (Dox@nHA-FA) were synthesized and incorporated into gelatin/polycaprolactone/ hydroxyapatite (Gel/PCL/HA) scaffolds via 3D printing. The Gel/PCL/HA(Dox@HA-FA) scaffolds were extensively characterized for drug release, mechanical strength, microstructure, and degradation profile. In vivo, scaffolds with different compositions were implanted in tumor-bearing Balb/c mice, and their degradation was monitored by CT-scan. The optimized scaffold composition shown medium disintegration tendency within 14 days and superior handling properties. In the orthotopic breast cancer model, Gel/PCL/HA(Dox@HA-FA) scaffolds produced a 71. 8% reduction in tumor volume compared with untreated controls (P \u003C 0. 01), a 63. 0% reduction versus free Dox (P \u003C 0. 05), and a 41. 5% reduction versus Dox@HA-FA nanoparticles (P \u003C 0. 05) . In addition, the number of metastatic liver colonies was reduced by ~65% compared with free Dox and by ~48% compared with Dox@HA-FA (P \u003C 0. 05) . In the diffuse peritoneal metastasis model, Gel/PCL/HA(Dox@HA-FA) scaffolds led to a significant reduction (> 70%, P \u003C 0. 01) in peritoneal metastatic nodules, whereas the other groups showed widespread dissemination.  \n*Correspondence:  \nFatemeh Molaabasi[molaabasi.fatemeh@yahoo.com](molaabasi.fatemeh@yahoo.com)[ ](molaabasi.fatemeh@yahoo.com)Seyed Ali Poursamar[ali.poursamar@amt.mui.ac.ir](ali.poursamar@amt.mui.ac.ir)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nKefayat et al. Journal of Nanobiotechnology (2026) 24:39 Page 2 of 21  \nBiocompatibility was confirmed by histopathology and blood biochemistry, with no significant alterations in liver or kidney function markers compared with healthy controls (P >0. 05) . Importantly, the scaffolds’ radio-opaque properties enabled non-invasive CT monitorin","cbCais7i00OGl8j7","https://ap.wps.com/l/cbCais7i00OGl8j7","pdf",7782391,21,"English","# Abstract\n# Introduction","[{\"question\":\"What therapeutic goal do the 3D-printed intraperitoneal implants target?\",\"answer\":\"They aim to provide controlled, sustained chemotherapy drug release while reducing systemic toxicity, specifically for systemic treatment of metastatic breast cancer.\"},{\"question\":\"How are the drug-loaded constructs fabricated and enabled for imaging?\",\"answer\":\"Doxorubicin-loaded, folic acid-targeted, pH-sensitive nanohydroxyapatite nanocarriers are synthesized and incorporated into gelatin/polycaprolactone/hydroxyapatite (Gel/PCL/HA) scaffolds via 3D printing, with radio-opaque properties enabling CT monitoring of degradation.\"},{\"question\":\"What efficacy and monitoring outcomes were reported in vivo?\",\"answer\":\"In tumor-bearing Balb/c mice, scaffold degradation is monitored by CT-scan, and the optimized Gel/PCL/HA(Dox@HA-FA) composition shows substantial reductions in tumor volume and metastatic liver colonies, along with histopathology and blood biochemistry confirming biocompatibility.\"}]","3D printed, biodegradable, and biocompatible intraperitoneal implants loaded with folic acid-targeted/pH-sensitive/doxorubicinloaded hydroxyapatite nanoparticles for systemic treatment of metastatic breast cancer | PDF",1790193420,53,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9b5b330581ee83ac0653242743d8c4d8.webp",983,1310,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9108fed069afcc2254e9af2adfc5fac5.webp",982,1309,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53c48678d4945f6e1dc8ca854ec18a94.webp",981,1308,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a13dc1fa0a44c1b982617cb42618b619.webp",980,1306]